Viewpoint: Anti-biotechnology groups lining up against proposal that USDA take over regulation of genetically engineered animals, claiming ‘unknown dangers’

Credit: Andy Sacks/Getty Images
Credit: Andy Sacks/Getty Images

A potential shift in regulatory authority and oversight from the U.S. Food and Drug Administration to the USDA over genetically modified animals could dramatically change the industry.

The proposed changes cover a wide scope of regulatory framework and safety review process for “amenable species,” which ranges from cattle, horses and sheep to catfish, geese, ducks, pigeons and swine and the regulation of biotechnology. That includes how the USDA should define “off-target changes” for the “purpose of expedited review of animals” in certain cases and what kind of genetic modification, entities or activities should be given exemptions from regulations. It is regulatory framework the USDA calls more “flexible” for the regulation of certain animals modified or developed using genetic engineering.

Follow the latest news and policy debates on agricultural biotech and biomedicine? Subscribe to our newsletter.

Many in the natural food industry and environmental groups say more caution should be given before allowing more genetically engineered animals into the marketplace.


“GMOs are a gateway technology through which other far more powerful technologies are going to go through the portal,” says Loren Israelsen, founder and president of United Natural Products Alliance. “When you get into synthetic biology and a lot more sophisticated technologies, it’s a one-way go, and if you pull the trigger, you can’t pull it back.”

Read the original post

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Here’s where GM crops are grown around the world today

Infographic: Here’s where GM crops are grown around the world today

Do you know where biotech crops are grown in the world? This updated ISAAA infographics show where biotech crops were ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
Send this to a friend